Discriminant analysis of prognostic factors for malignant fibrous histiocytoma in soft tissue
β Scribed by Tetsuya Shinozaki; Kazuo Kato; Hideomi Watanabe; Takashi Yanagawa; Adel Refaat Ahmed; Kenji Takagishi
- Publisher
- Springer Japan
- Year
- 2001
- Tongue
- English
- Weight
- 233 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0949-2658
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To determine the value of proliferating cell nuclear antigen (PCNA) staining as a prognostic indicator in soft-tissue malignant fibrous histiocytoma (MFH), we studied 27 patients who underwent resection including an adequately wide margin but without chemotherapy. The survival rate of patients with
## Abstract ## BACKGROUND Prognostic factors for metastasis in soft tissue sarcoma govern decisions regarding adjuvant treatment. However, the significance of initial tumorβrelated prognostic factors over time is largely unknown. ## METHODS The current study included 338 patients with malignant
Background. Malignant fibrous histiocytoma (MFH) of bone is a rare bone tumor, and its prognosis has been controversial. Methods. Thirty-four patients with MFH of bone were examined clinicopathologically for prognostic factors. Results. The most common skeletal site of the tumor was the femur (15